Shopping Cart
- Remove All
Your shopping cart is currently empty
Onilcamotide, a cancer vaccine derived from the C-terminal peptide of the RhoC protein, exhibits potential immunomodulating and antineoplastic activities.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | Backorder |
| Description | Onilcamotide, a cancer vaccine derived from the C-terminal peptide of the RhoC protein, exhibits potential immunomodulating and antineoplastic activities. |
| Molecular Weight | 2293.78 |
| Formula | C96H177N39O24S |
| Cas No. | 1164096-85-8 |
| Relative Density. | no data available |
| Sequence Short | ATRAGLQVRKNKRRRGCPIL |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.